INKT MiNK Therapeutics, Inc.
Nasdaq · SEC CIK 1840229 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $46.6K 3 sales by 1 insiders
- Filings on record
- 127 since 2021-10-20, latest 2026-09-02 11:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ryan Barbara | Dir | — | $46.6K |
| Holcomb John Bradley | Dir | — | — |
| Kadlec Robert Peter | Dir | — | — |
| Behner Peter | Dir | — | — |
| Buell Jennifer | CEO | — | — |
| Corvese Brian | Dir | — | — |
| WIINBERG ULF | Dir | — | — |
Transactions 103
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-07-21 | 2022-07-18+ | INKT | WIINBERG ULF | Dir | P - Purchase | $1.38 | +20.0K | 298.3K | +7% | +$27.6K |
| D | 2021-10-20 | 2021-10-19 | INKT | AGENUS INC | 10% | C - Cnv Deriv | — | -5.45M | 26.33M | -17% | — |
| D | 2021-10-20 | 2021-10-19 | INKT | AGENUS INC | 10% | P - Purchase | $12.00 | +1.40M | 20.88M | +7% | +$16.80M |
Purchase Sale Sale after option exercise All abbreviations